feature of steatosis, and serum leptin seems to increase as hepatocyte steatosis develops. An enhanced release of leptin is accompanied by an decrease in sOB-R concentration, which suggests higher resistance of peripheral tissues towards the action of leptin.
INTRODUCTIONLeptin -the ob gene product -is a circulating 16-kDa peptide hormone secreted mainly by adipocytes of white fat tissue. It regulates food intake, body fat, insulin action, thermogenesis, induction of angiogenesis, and modulation of the immune system. Leptin synthesis in adipocytes is regulated by several hormones [1] . Leptin action in peripheral tissues involves interaction with specific transmembrane receptors. The leptin receptor (Ob-R), which is a member of the class-1 cytokine receptor family, may be an important determinant of leptin sensitivity. Ob-R was originally demonstrated in hypothalamic neurons, through which leptin regulates food intake and body weight [2] . Alongside several membrane-bound isoforms of Ob-R, with varying cytoplasmic length and with the same extracellular domain, a soluble form of the leptin receptor (sOb-R) can be demonstrated. sOb-R represents the main leptin-binding compound in plasma, which results in fractions of bound and free leptin in plasma [3] . The balance between the free form, the rapidly bioavailable compartment, and bound leptin regulates leptin bioavailability [4] . However, the precise pathophysiological role of sOb-R has not yet been defined.Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a common and potentially severe condition often associated with obesity, type 2 diabetes and
Abstract
AIM:To determine the role of leptin system in non-alcoholic fatty liver disease (NAFLD) development by delineating the changes in serum levels of leptin and soluble leptin receptor (sOB-R).
METHODS:Blood samples were collected from 30 consecutive patients with liver-biopsy-proven NAFLD and 30 patients with cholecystolithiasis (stationary phase) as controls. Serum leptin levels were determined by radioimmunoassay and concentration of sOB-R was measured by ELISA. Body mass index (BMI) was calculated for all subjects, and serum insulin, C-peptide, and lipoprotein levels were also detected.
RESULTS:Mean serum leptin level and BMI in the NAFLD group were significantly higher than in the controls (both P < 0.001), but mean sOB-R level was lower in the NAFLD group when compared to the controls. Both men and women in the NAFLD group had higher mean serum leptin levels and lower sOB-R levels than did the men and women in the control group (all P < 0.001). There was a significant negative correlation between serum leptin and sOB-R levels (r = -0.725, P < 0.001). Multivariate analysis showed that the percentage of hepatocyte steatosis, sex, BMI, and homeostasis model assessment of insulin resistance (HOMA IR) were independently related to serum leptin levels.
CONCLUSION:Elevated serum leptin seems to be a